HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Long-term satisfaction and tolerability with low-dose flutamide: a 20-year surveillance study on 120 hyperandrogenic women.

AbstractOBJECTIVE:
To evaluate the long-term safety, satisfaction and tolerability of flutamide therapy for female hyperandrogenism.
DESIGN:
A 20-year surveillance study.
METHODS:
Setting: Gynecology Department in a teaching hospital.
PATIENTS:
Hyperandrogenic women complaining for hirsutism treatment were followed between February 1995 and April 2015.
INTERVENTIONS:
Women received flutamide 125 or 250 mg/day alone (n = 55) or combined with oral contraceptives (n = 65).
MAIN OUTCOME MEASURES:
Adverse events, safety, tolerability satisfaction and efficacy were assessed every 6 months during all the follow-up. Lab tests including liver and lipid profiles were also recorded in each control.
RESULTS:
Patients under flutamide therapy showed significant improvements in hirsutism scores after 6 months of treatment with a maximum effect at 12 months that was maintained during all the therapy time. Satisfaction reported by patients with the efficacy of the drug in a visual scale was also high. A total of 54.2 % women presented one or more adverse effects during the follow-up; 33.3% showed at least one adverse effect possibly related with the study drug; and 24.1% withdrew from the study because of adverse effects. During the follow-up, as many as 89.9 % of patients abandoned flutamide. Reasons include: questions linked to medical problems (50%), attempt pregnancy (4%) and significant improvement in the symptomatology (35.8%).
CONCLUSIONS:
Flutamide is very effective for hirsutism treatment; however, adverse effects are very frequent and affect compliance.
AuthorsCamil Castelo-Branco, Claudio Hernández-Angeles, Lina Alvarez-Olivares, Juan Balasch
JournalGynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology (Gynecol Endocrinol) Vol. 32 Issue 9 Pg. 723-727 (Sep 2016) ISSN: 1473-0766 [Electronic] England
PMID27176209 (Publication Type: Journal Article)
Chemical References
  • Androgen Antagonists
  • Contraceptives, Oral, Hormonal
  • Flutamide
Topics
  • Adult
  • Androgen Antagonists (administration & dosage, adverse effects, pharmacology)
  • Contraceptives, Oral, Hormonal (therapeutic use)
  • Drug Therapy, Combination
  • Female
  • Flutamide (administration & dosage, adverse effects, pharmacology)
  • Follow-Up Studies
  • Hirsutism (drug therapy)
  • Humans
  • Hyperandrogenism (drug therapy)
  • Medication Adherence
  • Middle Aged
  • Outcome Assessment, Health Care
  • Patient Satisfaction
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: